Sarepta Therapeutics | SRPT - PE Price to Earnings

Stock Price
17.55
Daily Change
-1.13 -6.05%
Monthly
-17.10%
Yearly
-51.83%
Q2 Forecast
17.20

Sarepta Therapeutics reported 27.27 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amgen 19.84 5.47 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Capricor Therapeutics 2.76K 2.76K Dec/2022
Daiichi Sankyo 20.73 1.74 Dec/2025
Eli Lilly 40.27 0.06 Mar/2026
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences 17.7 2.07 Mar/2026
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 28.09 807.38 Mar/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 9.32 5.16 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.84 0.14 Mar/2026
Sarepta Therapeutics 27.27 0 Dec/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Vertex Pharmaceuticals 25.82 0.33 Mar/2026